GENEVA, May 5 -- OTSUKA PHARMACEUTICAL CO., LTD. (2-9, Kanda Tsukasa-machi, Chiyoda-ku, Tokyo1018535) filed a patent application (PCT/JP2024/038053) for "COMPOUNDS AS CSF1R INHIBITORS" on Oct 25, 2024. With publication no. WO/2025/089370, the details related to the patent application was published on May 01, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): SUZUKI, Masaki (c/o OTSUKA PHARMACEUTICAL CO., LTD., 3-2-27, Otedori, Chuo-ku, Osaka-shi, Osaka5400021), BERDINI, Valerio (c/o Astex Therapeutics Ltd, 436 Cambridge Science Park, Milton Road, Cambridge CB4 0QA), YUKI, Yohei (c/o OTSUKA PHAR...